The western blot data verified the presence of PGAM2 in all EC patients, behaving as a marker for G1, G2, G3, G2-G3 and serous papillary adenocarcinoma EC phase. This evidence concerns the gene PGAM2 and papillary serous cystadenocarcinoma.